Cargando…

Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay

Interferon gamma (IFN-γ), a signal proinflammatory cytokine secreted by immune cell, and plays a critical role in the pathogenesis and progression of many diseases. It has been regarded as an important marker for determination of disease-specific immune responses. Therefore, it is urgent to develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hang, Zhong, Yanfang, Wang, Juncheng, Zhang, Qinghong, Li, Xiulan, Ling, Sumei, Wang, Shihua, Wang, Rongzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850876/
https://www.ncbi.nlm.nih.gov/pubmed/29563896
http://dx.doi.org/10.3389/fmicb.2018.00261
_version_ 1783306299352547328
author Yang, Hang
Zhong, Yanfang
Wang, Juncheng
Zhang, Qinghong
Li, Xiulan
Ling, Sumei
Wang, Shihua
Wang, Rongzhi
author_facet Yang, Hang
Zhong, Yanfang
Wang, Juncheng
Zhang, Qinghong
Li, Xiulan
Ling, Sumei
Wang, Shihua
Wang, Rongzhi
author_sort Yang, Hang
collection PubMed
description Interferon gamma (IFN-γ), a signal proinflammatory cytokine secreted by immune cell, and plays a critical role in the pathogenesis and progression of many diseases. It has been regarded as an important marker for determination of disease-specific immune responses. Therefore, it is urgent to develop a feasible and accurate method to detect IFN-γ in clinic real blood samples. Until now, the immunoassay based on singe chain variable fragment (scFv) antibody for human IFN-γ is still not reported. In the present study, an scFv antibody named scFv-A8 with high specificity was obtained by phage display and biopanning, with the affinity 2.6 × 10(9) L/mol. Maltose binding protein (MBP) was used to improve the solubility of scFv by inserting an linker DNA between scFv and MBP tag, and the resulted fusion protein (MBP-LK-scFv) has high solubility and antigen biding activity. The expressed and purified MBP-LK-scFv antibody was used to develop the indirect competitive enzyme-linked immunosorbent assay (ELISA) (ic-ELISA) for detection of human IFN-γ, and the result indicated that the linear range to detect IFN-γ was 6–60 pg/mL with IC(50) of 25 pg/mL. The limit of detection was 2 pg/mL (1.3 fm), and the average recovery was 85.05%, further demonstrating that the detection method based on scFv has higher recovery and accuracy. Hence, the developed ic-ELISA can be used to detect IFN-γ in real samples, and it may be further provided a scientific basis for disease diagnosis.
format Online
Article
Text
id pubmed-5850876
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58508762018-03-21 Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay Yang, Hang Zhong, Yanfang Wang, Juncheng Zhang, Qinghong Li, Xiulan Ling, Sumei Wang, Shihua Wang, Rongzhi Front Microbiol Microbiology Interferon gamma (IFN-γ), a signal proinflammatory cytokine secreted by immune cell, and plays a critical role in the pathogenesis and progression of many diseases. It has been regarded as an important marker for determination of disease-specific immune responses. Therefore, it is urgent to develop a feasible and accurate method to detect IFN-γ in clinic real blood samples. Until now, the immunoassay based on singe chain variable fragment (scFv) antibody for human IFN-γ is still not reported. In the present study, an scFv antibody named scFv-A8 with high specificity was obtained by phage display and biopanning, with the affinity 2.6 × 10(9) L/mol. Maltose binding protein (MBP) was used to improve the solubility of scFv by inserting an linker DNA between scFv and MBP tag, and the resulted fusion protein (MBP-LK-scFv) has high solubility and antigen biding activity. The expressed and purified MBP-LK-scFv antibody was used to develop the indirect competitive enzyme-linked immunosorbent assay (ELISA) (ic-ELISA) for detection of human IFN-γ, and the result indicated that the linear range to detect IFN-γ was 6–60 pg/mL with IC(50) of 25 pg/mL. The limit of detection was 2 pg/mL (1.3 fm), and the average recovery was 85.05%, further demonstrating that the detection method based on scFv has higher recovery and accuracy. Hence, the developed ic-ELISA can be used to detect IFN-γ in real samples, and it may be further provided a scientific basis for disease diagnosis. Frontiers Media S.A. 2018-03-07 /pmc/articles/PMC5850876/ /pubmed/29563896 http://dx.doi.org/10.3389/fmicb.2018.00261 Text en Copyright © 2018 Yang, Zhong, Wang, Zhang, Li, Ling, Wang and Wang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Yang, Hang
Zhong, Yanfang
Wang, Juncheng
Zhang, Qinghong
Li, Xiulan
Ling, Sumei
Wang, Shihua
Wang, Rongzhi
Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay
title Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay
title_full Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay
title_fullStr Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay
title_full_unstemmed Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay
title_short Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay
title_sort screening of a scfv antibody with high affinity for application in human ifn-γ immunoassay
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850876/
https://www.ncbi.nlm.nih.gov/pubmed/29563896
http://dx.doi.org/10.3389/fmicb.2018.00261
work_keys_str_mv AT yanghang screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay
AT zhongyanfang screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay
AT wangjuncheng screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay
AT zhangqinghong screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay
AT lixiulan screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay
AT lingsumei screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay
AT wangshihua screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay
AT wangrongzhi screeningofascfvantibodywithhighaffinityforapplicationinhumanifngimmunoassay